pressure <strong>and</strong> volume from the diffusion of nitrousoxide <strong>in</strong>to closed air-conta<strong>in</strong><strong>in</strong>g cavities <strong>and</strong> is thereforecontra<strong>in</strong>dicated <strong>in</strong> the presence of pneumothorax.Frequent side effects <strong>in</strong>clude euphoria,dis<strong>in</strong>hibition, dizz<strong>in</strong>ess, dry mouth, <strong>and</strong> disorientation.Nausea <strong>and</strong> vomit<strong>in</strong>g can occur. Excessive sedationis managed by discont<strong>in</strong>uation of the gas,oxygen adm<strong>in</strong>istration, <strong>and</strong> basic airway management.Prolonged or frequent use may affect folate metabolismlead<strong>in</strong>g to megaloblastic changes <strong>in</strong> the bonemarrow, megaloblastic anemia, <strong>and</strong> peripheral neuropathy.Depression of white cell formation may alsooccur. Patients who receive N 2 O more frequentlythan twice every 4 days should have regular bloodcell exam<strong>in</strong>ation for megaloblastic changes <strong>and</strong> neutrophilhypersegmentation.Exposure to prolonged high concentrations of N 2 Ohas been associated with reduced fertility <strong>in</strong> men <strong>and</strong>women. It should only be used <strong>in</strong> a well-ventilatedenvironment, which should be monitored <strong>and</strong> ma<strong>in</strong>ta<strong>in</strong>edbelow the UK Occupational Exposure St<strong>and</strong>ardfor atmospheric levels of N 2 O that is 37 2.0 ml maximumEach ‘dip’ of the pacifier is estimated to be 0.2 ml.The effectiveness of sucrose appears to decrease withage, at present it’s use as a primary analgesic shouldbe conf<strong>in</strong>ed to the neonatal period until further <strong>in</strong>formationis available.6.8.2 Sucrose side effects <strong>and</strong> toxicityCough<strong>in</strong>g, chok<strong>in</strong>g, gagg<strong>in</strong>g, <strong>and</strong> transient oxygen desaturationshave been reported; when us<strong>in</strong>g the syr<strong>in</strong>gemethod, the solution should be applied carefully to thetongue one drop at a time. There is some evidence thatadverse effects of sucrose, <strong>in</strong>clud<strong>in</strong>g a temporary<strong>in</strong>crease <strong>in</strong> ‘Neurobiologic Risk’ score, is more frequent<strong>in</strong> very premature <strong>in</strong>fants, particularly those
steps that health care professionals will perform); thesensations the patient can expect to feel (e.g., sharpscratch, numbness); <strong>and</strong> about how to cope with theprocedure.l Relaxation is a state of relative freedom from anxiety<strong>and</strong> skeletal muscle tension, a quiet<strong>in</strong>g or calm<strong>in</strong>gof the m<strong>in</strong>d <strong>and</strong> muscles.Further read<strong>in</strong>gBNFC: The British National Formulary for Children,Vol. 2nd Edition. London: BMJ Publish<strong>in</strong>g GroupLtd, 2012.References1 Morton NS. Ropivaca<strong>in</strong>e <strong>in</strong> children. Br JAnaesth 2000; 85: 344–346.2 Berde C. Local anaesthetics <strong>in</strong> <strong>in</strong>fants <strong>and</strong>children: an update. Pediatr Anesth 2004;14: 387–393.3 Bosenberg A. Pediatric regional anesthesiaupdate. Pediatr Anesth 2004; 14: 398–402.4 Mazoit J, Dalens B. Pharmacok<strong>in</strong>etics oflocal anaesthetics <strong>in</strong> <strong>in</strong>fants <strong>and</strong> children.Cl<strong>in</strong> Pharmacok<strong>in</strong>et 2004; 43: 17–32.5 Persson J. Wherefore ketam<strong>in</strong>e? Curr Op<strong>in</strong>Anaesthesiol 2010; 23: 455–460.6 Dahmani S, Michelet D, Abback PS et al.Ketam<strong>in</strong>e for perioperative pa<strong>in</strong> management<strong>in</strong> children: a meta-analysis of publishedstudies. Pediatr Anesth 2011; 21: 636–652.7 Basker S, S<strong>in</strong>gh G, Jacob R. Clonid<strong>in</strong>e <strong>in</strong>paediatrics – a review. Indian J Anaesth2009; 53: 270–280.8 Schnabel A, Poepp<strong>in</strong>g DM, Kranke P et al.Efficacy <strong>and</strong> adverse effects of ketam<strong>in</strong>e asan additive for paediatric caudal anaesthesia:a quantitative systematic review of r<strong>and</strong>omizedcontrolled trials. Br J Anaesth2011; 107: 601–611.9 Engelman E, Marsala C. Bayesian enhancedmeta-analysis of post-operative analgesicefficacy of additives for caudal analgesia <strong>in</strong>children. Acta Anaesthesiol Sc<strong>and</strong> 2012;Epub ahead of pr<strong>in</strong>t.10 Kart T, Christrup L, Rasmussen M. Recommendeduse of morph<strong>in</strong>e <strong>in</strong> neonates,<strong>in</strong>fants <strong>and</strong> children based on a literaturereview: part 2 – cl<strong>in</strong>ical use. Paediatr Anaesth1997; 7: 93–101.11 Kart T, Christrup L, Rasmussen M. Recommendeduse of morph<strong>in</strong>e <strong>in</strong> neonates,<strong>in</strong>fants <strong>and</strong> children based on a literaturereview: part 1 – pharmacok<strong>in</strong>etics. PaediatrAnaesth 1997; 7: 5–11.12 Kalso E. Oxycodone. J Pa<strong>in</strong> Symptom Manage2005; 29(Suppl): S47–S56.13 Grond S, Sablotzki A. Cl<strong>in</strong>ical pharmacologyof tramadol. Cl<strong>in</strong> Pharmacok<strong>in</strong>et 2004;43: 879–923.14 Allegaert K, de Hoon J, Van Overmeire Bet al. Cl<strong>in</strong>ical pharmacology of non opioidanalgesics <strong>in</strong> neonates. Verh K Acad GeneeskdBelg 2005; 67: 289–315.15 Lesko S, Mitchell A. An assessment of thesafety of pediatric ibuprofen. A practitionerbasedr<strong>and</strong>omized cl<strong>in</strong>ical trial. JAMA1995; 273: 929–933.16 Anderson B, Anderson M, Hastie B. Paracetamolprescrib<strong>in</strong>g habits <strong>in</strong> a children’shospital. N Z Med J 1996; 109: 376–378.17 Anderson B. Acetam<strong>in</strong>ophen analgesia <strong>in</strong><strong>in</strong>fants. Anesth Analg 2001; 93: 1626–1627.18 Bruce E, Franck L. Self-adm<strong>in</strong>isterednitrous oxide (Entonox) for the managementof procedural pa<strong>in</strong>. Pediatr Nurs 2000; 12:15–19.19 Lefrak L, Burch K, Caravantes R et al.Sucrose analgesia: identify<strong>in</strong>g potentiallybetter practices. Pediatrics 2006; 118(Suppl.2): S197–S202.20 Slater R, Cornelissen L, Fabrizi L et al.Oral sucrose as an analgesic drug for proceduralpa<strong>in</strong> <strong>in</strong> newborn <strong>in</strong>fants: a r<strong>and</strong>omisedcontrolled trial. Lancet 2010; 376: 1225–1232.21 Bellieni C, Bagnoli F, Perrone S et al. Effectof multisensory stimulation on analgesia <strong>in</strong>term neonates: a r<strong>and</strong>omized controlledtrial. Pediatr Res 2002; 51: 460–463.22 Cignacco E, Hamers JPH, Stoffel L et al.Rout<strong>in</strong>e procedures <strong>in</strong> NICUs: factors <strong>in</strong>fluenc<strong>in</strong>gpa<strong>in</strong> assessment <strong>and</strong> rank<strong>in</strong>g by pa<strong>in</strong><strong>in</strong>tensity. Swiss Med Wkly 2008; 138: 484–491.23 Uman LS, Chambers CT, McGrath PJ etal. Psychological <strong>in</strong>terventions for needlerelatedprocedural pa<strong>in</strong> <strong>and</strong> distress <strong>in</strong>children <strong>and</strong> adolescents. CochraneDatabase Syst Rev 2006; Oct 18;(4):CD005179.ª 2012 Blackwell Publish<strong>in</strong>g Ltd, Pediatric Anesthesia, 22 (Suppl. 1), 1–79 79
- Page 1 and 2:
PediatricAnesthesiaVolume 22 Supple
- Page 3 and 4:
doi: 10.1111/j.1460-9592.2012.3838.
- Page 5 and 6:
1.6 Contact informationCorresponden
- Page 7 and 8:
RecommendationsChildren’s self-re
- Page 9 and 10:
Topical anesthetic preparations, fo
- Page 11 and 12:
2.7.6 Laparoscopic surgeryGood prac
- Page 13 and 14:
In order to assess pain, effective
- Page 16 and 17:
Postoperative painl NCCPC-PV (Non-C
- Page 18 and 19:
68 Broome ME, Richtsmeier A, Maikle
- Page 20 and 21:
however, reductions in the response
- Page 22 and 23:
increased success rate (i.e., less
- Page 24 and 25:
Newer preparations such as liposoma
- Page 26 and 27:
Good practice pointLubricant contai
- Page 28 and 29:
most effective. There are a number
- Page 30 and 31: 12 Bellieni C, Bagnoli F, Perrone S
- Page 32 and 33: venipuncture pain in a pediatric em
- Page 34 and 35: 172 van Twillert B, Bremer M, Faber
- Page 36 and 37: necessary to ensure that the patien
- Page 38 and 39: when compared with LA alone and sal
- Page 40 and 41: Peribulbar block improves early ana
- Page 42 and 43: Analgesia Table 5.5.1 Sub-umbilical
- Page 44 and 45: was more effective with less motor
- Page 46 and 47: with using landmark techniques (205
- Page 48 and 49: Good practice pointWound infiltrati
- Page 50 and 51: Analgesia Table 5.6.4 Urological Su
- Page 52 and 53: (298). Ketorolac did not influence
- Page 54 and 55: well as the epidural technique for
- Page 56 and 57: Good practice pointA multi-modal an
- Page 58 and 59: 14 Grainger J, Saravanappa N. Local
- Page 60 and 61: day-stay unit. Int J Paediatr Dent
- Page 62 and 63: tinuous epidural infusion in childr
- Page 64 and 65: 245 Morton NS, O’Brien K. Analges
- Page 66 and 67: 321 Taenzer AH, Clark C, Taenzer AH
- Page 68 and 69: Section 6.0AnalgesiaContents6.1 Ana
- Page 70 and 71: enhance systemic absorption. Lidoca
- Page 73 and 74: undergoes hepatic biotransformation
- Page 75 and 76: tein binding are reduced and the ha
- Page 77 and 78: a low-dose infusion but the child m
- Page 79: Table 6.6.1 Paracetamol dosing guid